GT Biopharma, Inc. GTBP
3.93 USD -0.04 (-0.88%)
Nov 11, 2026, 2:54 PM EST
3.86 Day range 4.03
3.86 52-week range 28.75
- YTD
- +400.00%
- 1 year
- +480.62%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 12.42M | 14.36M | 13.58M | 21.26M | 57.52M | |
| 3.47M | 5.80M | 6.47M | 8.81M | 9.59M | |
| 8.95M | 8.57M | 7.11M | 12.45M | 47.92M | |
| -12.42M | -14.36M | -13.58M | -21.26M | -57.52M | |
| 127.00K | 0 | 213.00K | 8.00K | 718.00K | |
| -28.35M | -13.16M | -7.60M | -20.88M | -58.01M | |
| -34.45M | -13.16M | -7.60M | -20.88M | -58.01M | |
| -34.45M | -13.16M | -7.60M | -20.88M | -58.01M | |
| -28.35M | -13.16M | -7.60M | -20.88M | -58.01M | |
| -167.00 | -174.00 | -141.00 | -492.00 | -1,545.00 | |
| -167.00 | -174.00 | -141.00 | -492.00 | -1,545.00 | |
| -167.00 | -174.00 | -141.00 | -492.00 | -1,545.00 | |
| -28.23M | -13.16M | -7.38M | -20.88M | -57.30M | |
| -28.23M | -13.16M | -7.38M | -20.88M | -57.30M | |
| 6.09M | 0 | 0 | 0 | 0 | |
| 220.53K | 75.89K | 53.91K | 42.49K | 37.54K | |
| 220.53K | 75.89K | 53.91K | 42.49K | 37.54K |